BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 38148841)

  • 21. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
    Jayasree PJ; Dutta S; Karemore P; Khandelia P
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel insights into the regulatory role of N6-methyladenosine methylation modified autophagy in sepsis.
    Bi CF; Liu J; Hu XD; Yang LS; Zhang JF
    Aging (Albany NY); 2023 Dec; 15(24):15676-15700. PubMed ID: 38112620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N6-methyladenine RNA modification and cancer.
    Yang J; Chen J; Fei X; Wang X; Wang K
    Oncol Lett; 2020 Aug; 20(2):1504-1512. PubMed ID: 32724392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between N6-methyladenosine and autophagy in the regulation of bone and tissue degeneration.
    Wen X; Wang J; Wang Q; Liu P; Zhao H
    Front Bioeng Biotechnol; 2022; 10():978283. PubMed ID: 36072293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N6-methyladenosine methylation in kidney injury.
    Wang Q; Fan X; Sheng Q; Yang M; Zhou P; Lu S; Gao Y; Kong Z; Shen N; Lv Z; Wang R
    Clin Epigenetics; 2023 Oct; 15(1):170. PubMed ID: 37865763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of m6A methylation in retinal diseases.
    Zhu X; Zhou C; Zhao S; Zheng Z
    Exp Eye Res; 2023 Jun; 231():109489. PubMed ID: 37084873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomly incorporated genomic N6-methyldeoxyadenosine delays zygotic transcription initiation in a cnidarian.
    Febrimarsa ; Gornik SG; Barreira SN; Salinas-Saavedra M; Schnitzler CE; Baxevanis AD; Frank U
    EMBO J; 2023 Aug; 42(15):e112934. PubMed ID: 37708295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic Modifications of mRNA and DNA in Plants.
    Liang Z; Riaz A; Chachar S; Ding Y; Du H; Gu X
    Mol Plant; 2020 Jan; 13(1):14-30. PubMed ID: 31863849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.
    Paramasivam A; Priyadharsini JV
    Br J Cancer; 2021 May; 124(10):1621-1622. PubMed ID: 33723389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitranscriptomic profiling of N6-methyladenosine-related RNA methylation in rat cerebral cortex following traumatic brain injury.
    Yu J; Zhang Y; Ma H; Zeng R; Liu R; Wang P; Jin X; Zhao Y
    Mol Brain; 2020 Jan; 13(1):11. PubMed ID: 31992337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N6-methyladenosine and Neurological Diseases.
    Zhang N; Ding C; Zuo Y; Peng Y; Zuo L
    Mol Neurobiol; 2022 Mar; 59(3):1925-1937. PubMed ID: 35032318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
    Imam H; Kim GW; Siddiqui A
    Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents.
    Lv J; Xing L; Zhong X; Li K; Liu M; Du K
    Biomed Pharmacother; 2023 Jun; 162():114583. PubMed ID: 36989722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism.
    Yang H; Li Y; Huang L; Fang M; Xu S
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytophthora methylomes are modulated by 6mA methyltransferases and associated with adaptive genome regions.
    Chen H; Shu H; Wang L; Zhang F; Li X; Ochola SO; Mao F; Ma H; Ye W; Gu T; Jiang L; Wu Y; Wang Y; Kamoun S; Dong S
    Genome Biol; 2018 Oct; 19(1):181. PubMed ID: 30382931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.